Cyclin-Dependent Kinase 1 Inhibition Potentiates the Proliferation of Tonsil-Derived Mesenchymal Stem Cells by Delaying Cellular Senescence

Mesenchymal stem cells (MSCs) have been widely used in tissue regeneration and stem cell therapy and are currently being tested in numerous clinical trials. Senescence-related changes in MSC properties have attracted considerable attention. Senescent MSCs exhibit a compromised potential for prolifer...

Full description

Saved in:
Bibliographic Details
Main Authors: Da Hyeon Choi, Kyeong Eun Lee, Yoon Shin Park
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2022/4302992
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850232961279983616
author Da Hyeon Choi
Kyeong Eun Lee
Yoon Shin Park
author_facet Da Hyeon Choi
Kyeong Eun Lee
Yoon Shin Park
author_sort Da Hyeon Choi
collection DOAJ
description Mesenchymal stem cells (MSCs) have been widely used in tissue regeneration and stem cell therapy and are currently being tested in numerous clinical trials. Senescence-related changes in MSC properties have attracted considerable attention. Senescent MSCs exhibit a compromised potential for proliferation; senescence acts as a stress response that prevents the proliferation of dysfunctional cells by inducing an irreversible cell cycle arrest. Here, we established a senescent MSC model using senescence-associated β-galactosidase, proliferation, and cell cycle assays. We further identified novel biomarker candidates for old, senescent tonsil-derived MSCs (TMSCs) using transcriptomics. A plot of the cellular senescence pathway showed cyclin-dependent kinase 1 (CDK1; +8-fold) and CDK2 (+2-fold), and transforming growth factor beta 2 (TGFB2; +2-fold) showed significantly higher expression in old TMSCs than in young TMSCs. The CDK family was shown to be related to cell cycle and proliferation, as confirmed by quantitative RT-PCR. As replicative senescence of TMSCs, the gene and protein expression of CDK1 was significantly increased, which was further validated by inhibiting CDK1 using an inhibitor and siRNA. Taken together, we suggest that the CDK1 can be used as a selective senescence biomarker of MSCs and broaden the research criteria for senescent mechanisms.
format Article
id doaj-art-0cdc7a2a318643d0a324ac382798bcc0
institution OA Journals
issn 1687-9678
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Stem Cells International
spelling doaj-art-0cdc7a2a318643d0a324ac382798bcc02025-08-20T02:03:01ZengWileyStem Cells International1687-96782022-01-01202210.1155/2022/4302992Cyclin-Dependent Kinase 1 Inhibition Potentiates the Proliferation of Tonsil-Derived Mesenchymal Stem Cells by Delaying Cellular SenescenceDa Hyeon Choi0Kyeong Eun Lee1Yoon Shin Park2Department of Biological Sciences and BiotechnologyDepartment of Biological Sciences and BiotechnologyDepartment of Biological Sciences and BiotechnologyMesenchymal stem cells (MSCs) have been widely used in tissue regeneration and stem cell therapy and are currently being tested in numerous clinical trials. Senescence-related changes in MSC properties have attracted considerable attention. Senescent MSCs exhibit a compromised potential for proliferation; senescence acts as a stress response that prevents the proliferation of dysfunctional cells by inducing an irreversible cell cycle arrest. Here, we established a senescent MSC model using senescence-associated β-galactosidase, proliferation, and cell cycle assays. We further identified novel biomarker candidates for old, senescent tonsil-derived MSCs (TMSCs) using transcriptomics. A plot of the cellular senescence pathway showed cyclin-dependent kinase 1 (CDK1; +8-fold) and CDK2 (+2-fold), and transforming growth factor beta 2 (TGFB2; +2-fold) showed significantly higher expression in old TMSCs than in young TMSCs. The CDK family was shown to be related to cell cycle and proliferation, as confirmed by quantitative RT-PCR. As replicative senescence of TMSCs, the gene and protein expression of CDK1 was significantly increased, which was further validated by inhibiting CDK1 using an inhibitor and siRNA. Taken together, we suggest that the CDK1 can be used as a selective senescence biomarker of MSCs and broaden the research criteria for senescent mechanisms.http://dx.doi.org/10.1155/2022/4302992
spellingShingle Da Hyeon Choi
Kyeong Eun Lee
Yoon Shin Park
Cyclin-Dependent Kinase 1 Inhibition Potentiates the Proliferation of Tonsil-Derived Mesenchymal Stem Cells by Delaying Cellular Senescence
Stem Cells International
title Cyclin-Dependent Kinase 1 Inhibition Potentiates the Proliferation of Tonsil-Derived Mesenchymal Stem Cells by Delaying Cellular Senescence
title_full Cyclin-Dependent Kinase 1 Inhibition Potentiates the Proliferation of Tonsil-Derived Mesenchymal Stem Cells by Delaying Cellular Senescence
title_fullStr Cyclin-Dependent Kinase 1 Inhibition Potentiates the Proliferation of Tonsil-Derived Mesenchymal Stem Cells by Delaying Cellular Senescence
title_full_unstemmed Cyclin-Dependent Kinase 1 Inhibition Potentiates the Proliferation of Tonsil-Derived Mesenchymal Stem Cells by Delaying Cellular Senescence
title_short Cyclin-Dependent Kinase 1 Inhibition Potentiates the Proliferation of Tonsil-Derived Mesenchymal Stem Cells by Delaying Cellular Senescence
title_sort cyclin dependent kinase 1 inhibition potentiates the proliferation of tonsil derived mesenchymal stem cells by delaying cellular senescence
url http://dx.doi.org/10.1155/2022/4302992
work_keys_str_mv AT dahyeonchoi cyclindependentkinase1inhibitionpotentiatestheproliferationoftonsilderivedmesenchymalstemcellsbydelayingcellularsenescence
AT kyeongeunlee cyclindependentkinase1inhibitionpotentiatestheproliferationoftonsilderivedmesenchymalstemcellsbydelayingcellularsenescence
AT yoonshinpark cyclindependentkinase1inhibitionpotentiatestheproliferationoftonsilderivedmesenchymalstemcellsbydelayingcellularsenescence